BG97446A - Pharmaceutical compositions of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole - Google Patents
Pharmaceutical compositions of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazoleInfo
- Publication number
- BG97446A BG97446A BG97446A BG9744693A BG97446A BG 97446 A BG97446 A BG 97446A BG 97446 A BG97446 A BG 97446A BG 9744693 A BG9744693 A BG 9744693A BG 97446 A BG97446 A BG 97446A
- Authority
- BG
- Bulgaria
- Prior art keywords
- methylthiazole
- hydroxyethyl
- chloro
- pharmaceutical compositions
- solvate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9002659A SE9002659D0 (sv) | 1990-08-15 | 1990-08-15 | New pharmaceutical formulations |
PCT/SE1991/000522 WO1992003134A1 (en) | 1990-08-15 | 1991-08-07 | New pharmaceutical formulations of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole |
Publications (1)
Publication Number | Publication Date |
---|---|
BG97446A true BG97446A (en) | 1994-03-24 |
Family
ID=20380161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG97446A BG97446A (en) | 1990-08-15 | 1993-02-15 | Pharmaceutical compositions of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole |
Country Status (26)
Country | Link |
---|---|
US (1) | US5385921A (pt) |
EP (1) | EP0619734B1 (pt) |
JP (1) | JP3094077B2 (pt) |
AT (1) | ATE164066T1 (pt) |
AU (1) | AU657490B2 (pt) |
BG (1) | BG97446A (pt) |
CA (1) | CA2088775A1 (pt) |
CZ (1) | CZ279586B6 (pt) |
DE (1) | DE69129126T2 (pt) |
DK (1) | DK0619734T3 (pt) |
ES (1) | ES2114891T3 (pt) |
FI (1) | FI930608A0 (pt) |
HU (1) | HUT65821A (pt) |
IE (1) | IE912818A1 (pt) |
IL (1) | IL99169A (pt) |
IS (1) | IS3743A7 (pt) |
LT (1) | LT3978B (pt) |
LV (1) | LV10921B (pt) |
NO (1) | NO303447B1 (pt) |
NZ (1) | NZ239329A (pt) |
PT (1) | PT98688B (pt) |
RO (1) | RO112994B1 (pt) |
RU (1) | RU2093155C1 (pt) |
SE (1) | SE9002659D0 (pt) |
SK (1) | SK8793A3 (pt) |
WO (1) | WO1992003134A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9901658D0 (sv) * | 1999-05-06 | 1999-05-06 | Astra Ab | New formulation |
SE9904177D0 (sv) * | 1999-11-18 | 1999-11-18 | Astra Ab | Novel compounds |
US6699866B2 (en) | 2001-04-17 | 2004-03-02 | Sepracor Inc. | Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof |
CN103772313B (zh) * | 2014-01-02 | 2015-10-14 | 郑桂富 | 一种4-甲基-5-(2-羟乙基)噻唑的合成方法 |
CN112262814A (zh) * | 2020-10-26 | 2021-01-26 | 宜宾学院 | 油樟叶渣发酵床养鸡方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2825966A1 (de) * | 1978-06-14 | 1980-01-03 | Basf Ag | Saures galvanisches nickelbad, das sulfobetaine als glanz- und einebnungsmittel enthaelt |
GB8600783D0 (en) * | 1986-01-14 | 1986-02-19 | Merck Sharp & Dohme | N-methyl-d-aspartate receptor antagonists |
-
1990
- 1990-08-15 SE SE9002659A patent/SE9002659D0/xx unknown
-
1991
- 1991-08-07 JP JP03514007A patent/JP3094077B2/ja not_active Expired - Lifetime
- 1991-08-07 AT AT91915138T patent/ATE164066T1/de not_active IP Right Cessation
- 1991-08-07 DE DE69129126T patent/DE69129126T2/de not_active Expired - Lifetime
- 1991-08-07 RU RU9193004984A patent/RU2093155C1/ru active
- 1991-08-07 WO PCT/SE1991/000522 patent/WO1992003134A1/en active IP Right Grant
- 1991-08-07 EP EP91915138A patent/EP0619734B1/en not_active Expired - Lifetime
- 1991-08-07 SK SK8793A patent/SK8793A3/sk unknown
- 1991-08-07 RO RO93-00194A patent/RO112994B1/ro unknown
- 1991-08-07 CZ CS93166A patent/CZ279586B6/cs unknown
- 1991-08-07 AU AU84092/91A patent/AU657490B2/en not_active Ceased
- 1991-08-07 ES ES91915138T patent/ES2114891T3/es not_active Expired - Lifetime
- 1991-08-07 HU HU9300388A patent/HUT65821A/hu unknown
- 1991-08-07 DK DK91915138T patent/DK0619734T3/da active
- 1991-08-07 CA CA002088775A patent/CA2088775A1/en not_active Withdrawn
- 1991-08-09 IE IE281891A patent/IE912818A1/en unknown
- 1991-08-09 NZ NZ239329A patent/NZ239329A/en unknown
- 1991-08-12 IL IL9916991A patent/IL99169A/en active IP Right Grant
- 1991-08-14 PT PT98688A patent/PT98688B/pt not_active IP Right Cessation
- 1991-08-14 IS IS3743A patent/IS3743A7/is unknown
- 1991-08-14 US US07/744,914 patent/US5385921A/en not_active Expired - Lifetime
-
1993
- 1993-02-09 NO NO930452A patent/NO303447B1/no not_active IP Right Cessation
- 1993-02-11 FI FI930608A patent/FI930608A0/fi unknown
- 1993-02-15 BG BG97446A patent/BG97446A/xx unknown
- 1993-08-10 LV LVP-93-1024A patent/LV10921B/en unknown
- 1993-12-30 LT LTIP1714A patent/LT3978B/lt not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI932932A (fi) | Foerfarande och komposition foer desinfektering av kontaktlinser | |
AU9130691A (en) | Stable suspension formulations for controlled delivery of pharmaceutical compounds | |
MX9602837A (es) | Composiciones cosmeticas o farmaceuticas que contienen mangiferina o sus derivados. | |
MX9200146A (es) | Composiciones farmaceuticas deglutibles | |
BG97446A (en) | Pharmaceutical compositions of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole | |
AU8225391A (en) | The use of inositolmonophosphate for the preparing of a medicament effective as a neuropeptide gamma-antagonist | |
IL98198A0 (en) | Pharmaceutical compositions containing a derivative of substituted-l-valyl-l-prolinamide | |
TR27833A (tr) | Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu. | |
EP0650723A3 (en) | New pharmaceutical uses of forskolin derivatives. | |
IL97509A0 (en) | Lipid lowering compositions comprising bambuterol | |
TW325472B (en) | A pharmaceutical composition for preventing cancer comprising 2-(1-hydroxyethyl)-5-hydroxynaphto[2,3-b]furan-4,9-dione | |
NZ239187A (en) | Substituted 2-(9-fluorenonyl)-carbapenem derivatives, pharmaceutical compositions, and intermediates | |
RU93004984A (ru) | Фармацевтическая композиция на основе 5(2-хлор-1-гидроксиэтил)-4-метилтиазола, применение 5-(2-хлор-1-гидроксиэтил)-4-метил-тиазола для лечения, способ лечения, соли 5-(2-хлор-1-гидроксиэтил)-4-метилтиазола | |
IE813082L (en) | Cis-c3",c4"-carbonate derivatives of oleandomycin-y | |
FI930967A (fi) | Substituerade 6,7-dihydroimidazo(1,5,4-ef)(1,5)bensodiazepin-6-oner, deras framstaellning och farmaceutiska kompositioner | |
EP0509098A4 (en) | Ataractic | |
IT9022493A0 (it) | Composizione farmaceutica a rilascio controllato contenente un sale farmaceuticamente accettabile di buflomedil | |
MX9203359A (es) | Nuevas composiciones farmaceuticas de insulina. | |
AU636721C (en) | Pharmaceutical iodine compositions | |
IE901230L (en) | Ocular hypotensive pharmaceutical compositions | |
AU4930797A (en) | New ellipticine compounds, a process for their preparation and pharmaceutical compositions containing them | |
IT9048110A0 (it) | Composizioni farmaceutiche per la somministrazione rettale di calcitonina | |
IT1100372B (it) | Associazione di antibiotici caratterizzata da diminuita tossicita',e composizioni farmaceutiche relative |